Altamedica

What Altamedica does

Altamedica is a multi-specialty medical diagnostic and clinical center headquartered in Rome, Italy, operating under the corporate entity Artemisia SpA. The facility delivers an integrated portfolio of healthcare services organized around seven core pillars: prenatal diagnosis (including amniocentesis, villocentesis, the Multiprenatal Test, and the FetalDNA non-invasive prenatal testing sub-brand), a medical genetics laboratory with in-house NGS Next Generation Sequencing, medically assisted reproduction (PMA/IVF) with on-site preimplantation genetic diagnostics (PGD-PGS), diagnostic imaging (obstetric and gynecological ultrasound, digital radiology, 3D mammography with tomosynthesis, DEXA bone densitometry), clinical laboratory testing (including COVID-19 diagnostics), specialist outpatient services across cardiology, dermatology, neurology, orthopedics and other fields, and digital patient services (online booking and an online results portal). It is self-described as the largest prenatal diagnosis center in Italy and one of the largest globally, with over 40 years of operating history anchored by Medical Director Prof. Claudio Giorlandino.

The center serves three principal customer segments: pregnant women and expectant mothers (the primary segment, described as 'thousands monthly' for prenatal services), couples seeking fertility and reproductive medicine, and general patients requiring diagnostic services. Revenue is generated through SSN (Italian National Health Service) accreditation, private pay, insurance conventions, and corporate employer agreements, with a B2B laboratory service stream supplying clinical and genetic testing to other Italian healthcare facilities — a role in which Altamedica claims to be the first in Italy for invasive and non-invasive prenatal diagnosis. The center holds UNI EN ISO 9001:2015 certification, operates under a Model 231/01 anti-crime compliance framework, and is registered as a scientific research institute (001361_IMPR) in the Anagrafe Nazionale delle Ricerche. Strategic partnerships include Ospedale Pediatrico Bambino Gesù (2017, fetal-neonatal continuity of care) and Unicamillus International Medical University (2021, Master II level academic programs in obstetric-gynecological ultrasound and prenatal medicine). The facility is a privately held, single-location operator with no disclosed external institutional investment, no M&A activity, and no expansion beyond the Lazio region on record.

Name

Altamedica

Legal name

Artemisia SpA

Website

https://altamedica.it

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

51–100 employees

Short description

Altamedica is a Rome-based multi-specialty diagnostic and clinical center specializing in prenatal diagnosis, reproductive medicine, and genetic testing. It serves pregnant women, couples seeking fertility treatment, and general patients, operating as Italy's largest prenatal diagnosis center under Artemisia SpA.

Ownership category

akta.pro rank

Product category

Multi-specialty Diagnostic Healthcare Services

NAICS

Medical Laboratories (621511), Diagnostic Imaging Centers (621512), Ambulatory Health Care Services (621)

SIC

Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Maternal-Fetal Medicine (High-Risk Pregnancy) Centers (HLAFAJAB)

akta.pro secondary industries

Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Prenatal & Maternal-Fetal Diagnostic Imaging Centers (HLAFAKAL), Specialty & Biomarker Laboratory Services (Immunoassays/Flow/Cytometry) (HLAGAEAB)

Keywords

• Prenatal diagnosis services
• Reproductive medicine
• Medical genetics laboratory
• Diagnostic imaging services
• Clinical laboratory testing

Headquarters

HQ city

Roma

HQ country

Italy

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

1. Clinical and Diagnostic Services: Altamedica generates revenue through the provision of clinical diagnostic services including specialist consultations, laboratory tests, imaging diagnostics (ultrasound, radiology, mammography, etc.), prenatal diagnosis, genetic testing, and reproductive medicine services. The center operates under accreditation with the National Health Service (SSN) as well as private pay and insurance billing.
2. Laboratory Service Provider: Altamedica serves as a major laboratory analysis service provider nationally, being the first in Italy for invasive and non-invasive prenatal diagnosis. Revenue is generated through B2B laboratory service contracts with other healthcare facilities.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Altamedica is a multi-specialty medical diagnostic and clinical center in Rome that delivers prenatal diagnosis, reproductive medicine (PMA/IVF with on-site PGD-PGS), medical genetics laboratory services using NGS, diagnostic imaging (ultrasound, 3D mammography, digital radiology, DEXA), clinical laboratory testing, and specialist outpatient consultations. The center serves individual patients directly at its facility and online, and also operates as a B2B laboratory analysis service provider to other healthcare facilities across Italy.

Product overview

Altamedica is a multi-specialty medical diagnostic and clinical center in Rome, Italy, operating as part of the Artemisia SpA healthcare group. The facility offers an integrated portfolio of diagnostic and clinical services organized around several core pillars: (1) Prenatal Diagnosis including amniocentesis, villocentesis, Multiprenatal Test, and the FetalDNA sub-brand for non-invasive prenatal testing; (2) Medical Genetics Laboratory with NGS (Next Generation Sequencing) technology for whole genome analysis; (3) Medically Assisted Reproduction (PMA) with in-house pre-implantation genetic testing (PGD-PGS); (4) Diagnostic Imaging including ultrasound (obstetric, gynecological, cardiological, vascular), digital radiology, 3D mammography with tomosynthesis, and bone densitometry; (5) Clinical Laboratory services including COVID-19 testing; (6) Specialist outpatient services across cardiology, dermatology, neurology, orthopedics, and other specialties; and (7) Digital patient services including online booking and results portal. The center is recognized as one of Italy's largest prenatal diagnosis facilities with over 40 years of experience.

Differentiator

Problem solved

Functional benefit

Brands

• FetalDNA: DNA fetal testing service including Non-Invasive Prenatal Testing (NIPT) and genetic screening.
• Artemisia

Products and services

• Diagnosi Prenatale (Prenatal Diagnosis) Prenatal diagnosis services including amniocentesis, villocentesis, and genetic screening tests for detecting fetal abnormalities, targeted at pregnant women and expectant mothers.
• FetalDNA (Non-Invasive Prenatal Testing) Non-invasive prenatal testing (NIPT) service for fetal DNA analysis from maternal blood, including FetalDNA Base, FetalDNA Base Plus, FetalDNA Cariotipo, Cariotipo Plus, and Total Screen levels.
• Multiprenatal Test Advanced prenatal screening test combining multiple biomarkers from maternal blood for comprehensive fetal health assessment, including preterm birth risk prediction.
• Fertilità di Coppia / PMA (Medically Assisted Reproduction) Medically assisted reproduction services including homologous and heterologous IVF, with in-house preimplantation genetic testing (PGD-PGS), semen analysis, and reproductive counseling.
• Laboratorio di Genetica Medica (Medical Genetics Laboratory) Medical genetics laboratory offering molecular medicine, DNA studies, pharmacogenomics, nutrigenomics, NGS-based whole-genome analysis, and oncology genetic testing, serving both patients and other healthcare facilities.
• Diagnostica Ecografica (Diagnostic Ultrasound) Multispecialty ultrasound diagnostic services including obstetric, gynecological, cardiological, vascular, internal medicine, and pediatric ultrasounds, plus Uscom ultrasonic cardiac output monitoring.
• RX Radiologia Digitale e Mammografia 3D (Digital Radiology and 3D Mammography) Digital radiology services including 3D mammography with tomosynthesis, orthopanoramic imaging, and bone densitometry (DEXA/MOC) for osteoporosis screening.
• Esami di Laboratorio Clinico (Clinical Laboratory Testing) Clinical laboratory testing services including blood tests, hematology, and specialized diagnostics, with home blood draw service available.
• COVID-19 Testing Services COVID-19 testing services including rapid antigen swabs (nasopharyngeal, oropharyngeal, salivary), molecular testing, and antibody (IgG/IgM) serological tests, with combined serological + antigen (Combi Test) and quantitative anti-SARS-CoV-2 total antibody options.
• Pacchetti Analisi Cliniche (Clinical Analysis Packages) Pre-packaged clinical analysis bundles offering combined diagnostic tests at reduced pricing.
• Check-up Uomo/Donna Comprehensive preventive health check-up programs for men and women covering multiple diagnostic areas including laboratory, imaging, and specialist consultations.
• Deep TMS (Transcranial Magnetic Stimulation) Transcranial magnetic stimulation treatment service for psychiatric/neurological conditions, offered with a promotional package of 8 free sessions.
• Patologia Fetale e Gravidanza a Rischio (Fetal Pathology and High-Risk Pregnancy) High-risk pregnancy management and fetal pathology assessment with specialized monitoring, multidisciplinary consultation, and interventions.
• Laboratorio di Seminologia (Seminology Laboratory) Semen analysis and seminology laboratory with counseling services for male fertility assessment as part of reproductive medicine.
• Endoscopia Digestiva (Digestive Endoscopy) Digestive endoscopy services including gastroscopy and colonoscopy with polypectomy.
• Cardiologia e Visite Cardiologiche (Cardiology) Cardiology services including specialist consultations, home visits, and Uscom ultrasonic cardiac output monitoring.
• Biopsia Prostatica Fusion Biopsy Prostate biopsy using fusion biopsy technology combining MRI and ultrasound for enhanced prostate cancer targeting.
• Ozonoterapia (Ozone Therapy) Ozone therapy treatment for various medical conditions including orthopedic indications.
• Referti Online (Online Results Portal) Online patient portal allowing patients to access test results, make payments, and retrieve invoices remotely.

Quantifiable outcome

• COVID-19 antibody test: Sensitivity 95%, Specificity 99%, Accuracy 100% in healthy subjects
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Unicamillus – International Medical UniversitycoreStrategic or Co-development Partner · 1 January 2021Partnership between Altamedica and Unicamillus for the Master II level program in 'Obstetric-Gynecological Ultrasound, Diagnosis and Prenatal Medicine' (A.A. 2023-2024). The program represents a formal academic collaboration for training in Altamedica's core specialization areas.
• Ospedale Pediatrico Bambino GesùcoreStrategic or Co-development Partner · 1 January 2017Partnership established in 2017 between Altamedica and the Ospedale Pediatrico Bambino Gesù to improve fetal-neonatal continuity of care for pregnant women. The agreement includes free prenatal genetic counseling by OPBG specialists for Altamedica patients, fast-track access to fetal MRI at OPBG, and joint multidisciplinary teams across obstetrics, orthopedics, maxillofacial, neurology, neurosurgery, and urology. The partnership also encompasses teaching, dissemination, and research collaboration.
• Istituto d'Istruzione Superiore Luigi EinaudiminorOthers · 1 January 2017Work-study program (Alternanza Scuola Lavoro) agreement enabling students from the Luigi Einaudi secondary school (specializing in commercial services, graphics, socio-health, and tourism) to undertake internships at Altamedica.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Illumina: Illumina is the dominant global sequencing technology platform whose NGS instruments underpin nearly all NIPT and reproductive genetics testing worldwide. It is comparable to Altamedica as the upstream technology enabler for Altamedica's NGS-based FetalDNA and prenatal genomics capability.
• Bio-Rad Laboratories: Bio-Rad is a global life science and clinical diagnostics company providing instruments and reagents for clinical labs, including molecular diagnostics and quality controls. Comparable to Altamedica as a clinical diagnostics player serving hospital and reference laboratory customers.

Direct peers

• Lifebrain: Lifebrain is one of Italy's largest networks of clinical analysis laboratories, providing blood tests, genetic diagnostics, and specialized laboratory services with nationwide collection points. It competes directly with Altamedica's clinical laboratory and B2B lab service business across Italy.
• Natera: Natera is a US-based genetic testing company operating globally, with non-invasive prenatal testing (NIPT) as a flagship product (Panorama) alongside reproductive and oncology genetics. It is a direct competitor to Altamedica's FetalDNA NIPT and reproductive genetics service lines.
• GVM Care & Research: GVM Care & Research is a major Italian private hospital and outpatient group with multiple specialties including obstetrics, gynecology, and diagnostic services nationwide. Comparable to Altamedica as an Italian multi-specialty private healthcare provider with diagnostic and outpatient clinical offerings.
• Eurofins Genoma: Eurofins Genoma is the Italian specialty genetics laboratory of the Eurofins network, offering NIPT, prenatal diagnosis, carrier screening, and reproductive genetics. Comparable to Altamedica's medical genetics laboratory, NGS-based services, and B2B lab supply to other clinics.
• Synlab Italia: Synlab (HQ Germany) is one of Europe's largest clinical laboratory service networks with a strong Italian presence (Synlab Italia), offering laboratory diagnostics and B2B lab services to healthcare providers. Highly comparable to Altamedica's B2B laboratory service provider operations and clinical lab product portfolio.
• Genera (Clinica Genera): Genera is a leading Italian network of medically assisted reproduction and fertility clinics offering IVF, ICSI, and preimplantation genetic testing. It is directly comparable to Altamedica's PMA service line and its on-site PGD-PGS capability.
• Igenomix: Igenomix (part of Vitrolife Group) is a global leader in reproductive genetics, with deep specialization in PGT-A/PGT-M for IVF clinics. It competes head-to-head with Altamedica's on-site PGD/PGS service and pursues the same reproductive medicine specialists as referring customers.

Emerging players

• LifeCodexx: LifeCodexx is a European specialty NIPT provider headquartered in Germany offering non-invasive prenatal tests and supporting European reference labs. Comparable to Altamedica as a niche/emerging competitor in the same NIPT and prenatal diagnostics category across Europe.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/altamedicaroma
• Facebookfacebook.com/artemisiaspa
• LinkedInlinkedin.com/company/altamedica-healthcare-centers-roma---milano

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Altamedica